Economic Impact of a Rotavirus Vaccine in Brazil
AUTOR(ES)
Constenla, Dagna O.
FONTE
International Centre for Diarrhoeal Disease Research
RESUMO
The study was done to evaluate the cost-effectiveness of a national rotavirus vaccination programme in Brazilian children from the healthcare system perspective. A hypothetical annual birth-cohort was followed for a five-year period. Published and national administrative data were incorporated into a model to quantify the consequences of vaccination versus no vaccination. Main outcome measures included the reduction in disease burden, lives saved, and disability-adjusted life-years (DALYs) averted. A rotavirus vaccination programme in Brazil would prevent an estimated 1,804 deaths associated with gastroenteritis due to rotavirus, 91,127 hospitalizations, and 550,198 outpatient visits. Vaccination is likely to reduce 76% of the overall healthcare burden of rotavirus-associated gastroenteritis in Brazil. At a vaccine price of US$ 7-8 per dose, the cost-effectiveness ratio would be US$ 643 per DALY averted. Rotavirus vaccination can reduce the burden of gastroenteritis due to rotavirus at a reasonable cost-effectiveness ratio.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2740695Documentos Relacionados
- Detection and Characterization of Rotavirus G and P Types from Children Participating in a Rotavirus Vaccine Trial in Belém, Brazil
- The impact of the economic crisis on labor rights in Brazil
- Acute diarrhoea in a community cohort of children who received an oral rotavirus vaccine in Northeast Brazil
- Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
- Economic impact of treatment for surgical site infections in cases of total knee arthroplasty in a tertiary public hospital in Brazil
